Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital

Pharmacological Research

Volumn 54, Issue 3, 2006, Pages 226-233

  Jose, Jimmy ^a   Rao, Padma G M ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Adverse drug reactions; Pattern; Spontaneous reporting; Tertiary care hospital

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; AMOXICILLIN; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIMYCOBACTERIAL AGENT; ANTINEOPLASTIC AGENT; ANTIRHEUMATIC AGENT; ANTIVIRUS AGENT; AYURVEDIC DRUG; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; GABAPENTIN; HEPARIN; IBUPROFEN; ISONIAZID; LEVOFLOXACIN; LORAZEPAM; METHOTREXATE; PHENYTOIN; PREDNISONE; SALBUTAMOL; THEOPHYLLINE; UNINDEXED DRUG; WARFARIN;

ADOLESCENT; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; ATAXIA; BLOOD TOXICITY; CALCULATION; CARDIOVASCULAR DISEASE; CHILD; CONSTIPATION; DATA ANALYSIS; DEMOGRAPHY; DIARRHEA; DISEASE PREDISPOSITION; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG USE; ENDOCRINE DISEASE; FEMALE; GASTRITIS; GASTROINTESTINAL TOXICITY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; INCIDENCE; INDIA; INFANT; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NEPHROTOXICITY; NEUROPATHY; NEUTROPENIA; NEWBORN; NYSTAGMUS; OUTPATIENT; PANCYTOPENIA; PERIPHERAL EDEMA; POLYPHARMACY; PRIORITY JOURNAL; PRURITUS; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SKIN DISEASE; STATISTICAL SIGNIFICANCE; TERTIARY HEALTH CARE; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL; URTICARIA; VOMITING;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, TEACHING; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHENYTOIN; SEX FACTORS;

EID: 33746341518     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.05.003     Document Type: Article

References (37)

1. Ditto A.M. Drug allergy. In: Grammer L.C., and Greenberger P.A. (Eds). Patterson's allergic diseases. 6th ed. (2002), Lippincott Williams & Wilkins, Philadelphia 295
2. Jick H. Adverse drug reactions: the magnitude of the problem. J Allergy Clin Immunol 74 (1984) 555-557
3. Lazarou J., Pomeranz B.H., and Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (1998) 1200-1205
4. Hartwig S.C., Siegel J., and Schneider P.J. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 49 (1992) 2229-2232
5. American Society of Health System Pharmacists. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Hosp Pharm 46 (1989) 336-337
6. Murphy B.M., and Frigo L.C. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital. Hosp Pharm 28 12 (1993) 1199-1204 1240
7. Moride Y., Haramburu F., Requeyo A.A., and Begaud B. Underreporting of adverse drug reactions in general practice. Br J Clin Pharmacol 43 2 (1997) 177-181
8. Alvarez-Requejo A., Carvajal A., Begaud B., Moride Y., Vega T., and Martin Arias L.H. Under reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 54 (1998) 483-488
9. Gallelli L., Ferreri G., Colosimo M., Pirritano D., Flocco M.A., Pelaia G., et al. Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy. Pharmacol Res 47 6 (2003) 493-499
10. Wu W.K. Evaluation of outpatient adverse drug reactions leading to hospitalization. Am J Health-Syst Pharm 60 3 (2003) 253-259
11. Regal B. Finally a pharmacovigilant India. Uppsala Rep 25 (2004) 7-8
12. Adithan C. National pharmacovigilance program. Indian J Pharmacol 37 (2005) 347
13. Gallelli L., Ferreri G., Colosimo M., Pirritano D., Guadagnino L., Pelaia G., et al. Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: a six year retrospective study. Pharmacol Res 46 5 (2002) 395-400
14. Rawlins M.D., and Thompson J.W. Pathogenesis of adverse drug reactions. In: Davies D.M. (Ed). Textbook of adverse drug reactions. 1st ed. (1977), Oxford University Press, Oxford 44
15. European Commission. A guideline on summary of product characteristics, October 2005. http://pharmacos.eudra.org/F2/eudralex/vol-2/C/SPCGuidRev0-Dec99.pdf.
16. WHO Collaborating Centre for Drug Statistics Methodology. Completed ATC Index 2005. http://www.whocc.no/atcddd/.
17. Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 (1981) 239-245
18. Lau P.M., Stewart K., and Dooley M.J. Comment: hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 37 (2003) 303-312
19. Edwards I.R. Pharmacological basis of adverse drug reactions. In: Speight T.M., and Holford N.H.G. (Eds). Avery's drug treatment. 4th ed. (1997), Adis International, Auckland, New Zealand 261-299
20. Parthasarathi G., and Sten O. Adverse drug reactions. In: Parthasarathi G., Nyfort-Hansen K., and Nahata M.C. (Eds). A text book of clinical pharmacy practice-essential concepts and skills. 1st ed. (2004), Orient Longman Private Limited, Chennai 86-102
21. Veehof L.J.G., Stewart R.E., Haaijer-Ruskamp F.M., and Meyboom-de Jong B. The development of polypharmacy. A longitudinal study. Family Practice 17 3 (2000) 261-267
22. Bates D.W., Spell N., Cullen D.J., Burdick E., Laird N., Petersen L.A., et al. The cost of adverse drug events in hospitalized patients. JAMA 277 (1997) 307-311
23. Gonzalez-Martin G., Caroca C.M., and Paris E. Adverse drug reactions (ADRs) in hospitalized pediatric patients-a prospective study. Int J Clin Pharmacol Ther 36 10 (1998) 530-533
24. Impicciatore P., Choonara I., Clarkson A., Provasi D., Pandolfini C., and Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52 1 (2001) 77-83
25. Gholami K., and Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 33 2 (1999) 236-240
26. Bates D.W., Cullen D.J., Laird N., Petersen L.A., Small S.D., Servi D., et al. Incidence of adverse drug events and potential adverse drug events-implications for prevention. JAMA 274 1 (1995) 29-34
27. Bennett B.S., and Lipman A.G. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am J Hosp Pharm 34 (1977) 931-936
28. Montastruc J.L., Lapeyre-Mestre M., Bagheri H., and Fooladi A. Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France. Fundam Clin Pharmacol 16 5 (2002) 343-346
29. Suh D.C., Woodall B.S., Shin S.K., and Hermes-De-Santis E.R. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 34 (2000) 1373-1379
30. Prosser T.R., and Kamysz P.L. Multidisciplinary adverse drug reaction surveillance program. Am J Hosp Pharm 47 6 (1990) 1334-1339
31. Kanjanarat P., Winterstein A.G., Johns T.E., Hatton R.C., Gonzalez-Rothi R., and Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 60 (2003) 1750-1759
32. Bates D.W., Leape L.L., and Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 8 (1993) 289-294
33. Gandhi T.K., Weingart S.N., Borus J., Seger A.C., Peterson J., Burdick E., et al. Adverse drug events in ambulatory care. N Eng J Med 348 (2003) 1156-1164
34. Evans R.S., Lloyd J.F., Stoddard G.J., Neberker J.R., and Samore M.H. Risk factors for adverse drug events: a 10 year analysis. Ann Pharmacother 39 (2005) 1161-1168
35. Fonescue E.B., Kausbal R., Landrigan C.P., McKenna K.J., Clapp M.D., Federico F., et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics 111 4 Pt 1 (2003) 722-729
36. Field T.S., Gurwitz J.H., Avorn J., McCormick D., Jain S., Eckier M., et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 161 (2001) 1629-1634
37. Bates D.W., Miller E.B., Cullen D.J., Burdick L., Williams L., Laird N., et al. Patient risk factors for adverse drug events in hospitalized patients. Arch Intern Med 159 (1999) 2553-2559